RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Hastings, NE · +52 more sites
2 recruiting lung cancer studies with a site in Hastings, NE.
Sponsor: BioNTech SE
Hastings, NE · +52 more sites
Sponsor: University of Nebraska
Hastings, NE · Norfolk, NE · North Platte, NE · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.